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H9N2 influenza viruses have been circulating worldwide in multiple avian species 27 
and regularly infect pigs and humans. Recently, a novel protein PA-X, produced from 28 
the PA gene by ribosomal frameshifting, is demonstrated to be an anti-virulence factor 29 
in pandemic 2009 H1N1, highly pathogenic avian H5N1 and 1918 H1N1 viruses. 30 
However, a similar role of PA-X in the prevalent H9N2 avian influenza viruses has 31 
not been established. In this study, we compared the virulence and cytopathogenicity 32 
H9N2 wild type virus and H9N2 PA-X deficient virus. Loss of PA-X in H9N2 virus 33 
reduced apoptosis and had marginal effect on progeny virus output in human 34 
pulmonary adenocarcinoma (A549) cells. Without PA-X, PA was less able to suppress 35 
co-expressed green fluorescence protein (GFP) in human 293T cells. Furthermore, 36 
absence of PA-X in H9N2 virus attenuated viral pathogenicity in mice which showed 37 
no mortality, reduced progeny virus production, mild to normal lung histopathology, 38 
and dampened proinflammatory cytokine and chemokine response. Therefore, unlike 39 
previously reported H1N1 and H5N1 viruses, we show that PA-X protein in H9N2 40 
virus is a pro-virulence factor in facilitating viral pathogenicity, and that the pro- or 41 
anti-virulence role of PA-X in influenza viruses is virus-strain dependent.  42 
 43 




H9N2 influenza viruses have been circulating worldwide in poultry resulting in 48 
severe economic losses due to reduced egg production or increased mortality 49 
associated with co-infection with secondary pathogens (Banks et al., 2000; Bano et al., 50 
2003; Capua & Alexander, 2006). H9N2 influenza viruses have been widely reported 51 
to infect mammals, including pigs and humans (Abolnik et al., 2010; Butt et al., 2010; 52 
Cong et al., 2007; Sun et al., 2010; Xu et al., 2007); there is evidence that a large 53 
number of people have been infected with H9N2 viruses in particular poultry workers 54 
(Coman et al., 2013; Jia et al., 2009; Wang et al., 2009). H9N2 virus infections in 55 
humans showed typical human flu-like symptoms which can easily go undetected or 56 
unreported (Butt et al., 2005; Lin et al., 2000). Recent studies showed that H9N2 57 
viruses contributed the six internal genes to the novel H7N9 and H10N8 viruses that 58 
are causing severe human infections in China (Chen et al., 2014; Gao et al., 2013; 59 
Zhang et al., 2013). H9N2 viruses can be regarded as precursors to emerging subtypes 60 
of influenza viruses that are highly infectious to humans. Therefore, it is important to 61 
ascertain virulence factors of H9N2 viruses.  62 
Recently, PA-X, arising from ribosomal frame-shift in a +1 open reading frame 63 
(X-ORF) extension of a growing PA polypeptide, was identified as a protein  (Jagger 64 
et al., 2012). It was demonstrated that PA-X plays an important role in inhibiting 65 
cellular protein synthesis, suggesting that PA-X contributes to host-cell shut off 66 
induced by influenza virus (Desmet et al., 2013; Jagger et al., 2012; Katze et al., 67 
1986a; Katze et al., 1986b). Jagger et al. also showed that PA-X decreased the 68 
virulence of the 1918 H1N1 virus in a mouse model, through modulating host 69 
inflammatory response, apoptosis, cell differentiation and tissue remodeling (Jagger et 70 
al., 2012). We recently reported that loss of PA-X expression in 2009 pandemic H1N1 71 
(pH1N1) and highly pathogenic H5N1 viruses increases viral replication and 72 
apoptosis in A549 cells and increases virulence and host inflammatory response in 73 
mice (Gao et al., 2015). Loss of PA-X expression also increases the virulence and 74 
virus replication of H5N1 virus in avian species, and blunts the host innate immune 75 
and cell death response (Hu et al., 2015).  76 
Here we report that the absence of PA-X in H9N2 virus, contrary to previous 77 
findings on pH1N1, highly pathogenic H5N1 and 1918 H1N1 viruses, decreases viral 78 
replication and pro-inflammatory response in mice. The absence of PA-X in H9N2 79 
virus also reduces virus-induced suppression of cellular protein synthesis.  80 
 81 
Results 82 
Generation of PA-X deficient H9N2 virus 83 
In the present study, the use of reverse genetics was based on the 84 
A/chicken/Hebei/LC/2008 (H9N2 WT) virus (Sun et al., 2011). To evaluate the effect 85 
of loss of PA-X expression on viral function, we generated PA-X deficient virus, 86 
H9N2-FS, by altering the frameshifting motif from UCC UUU CGU to AGC UUC 87 
AGA in the PA segment to prevent the formation of PA-X (Fig.1a) (Jagger et al., 88 
2012). The mutations did not alter the PA ORF. To show that PA-X expression from 89 
H9N2-FS was abolished, Madin Darby Canine Kidney (MDCK) cells were infected 90 
with H9N2 PA-X mutant and WT viruses at an MOI of 1, and cell lysates were 91 
harvested at 12 hpi. We found that PA-X could be detected in H9N2 WT infected cells 92 
but not in H9N2-FS infected cells (Fig.1b). 93 
Decreased apoptosis in A549 cells infected with PA-X deficient H9N2 virus 94 
H9N2 WT and H9N2-FS were used to infect MDCK and human pulmonary 95 
adenocarcinoma (A549) cells at an MOI of 0.01, and the supernatants were collected 96 
and titrated at 6, 12, 24, 36, 48, 60, 72 and 84 h post infection (hpi). There was no 97 
significant difference in the virus output from MDCK cells between H9N2 WT and 98 
H9N2-FS viruses (Fig.2a). In A549 cells, H9N2-FS and H9N2WT viruses reached 99 
maximum virus output at around the same time (48 hpi) with comparable peak virus 100 
titers; viral titers at indicated time points showed no significant difference between 101 
H9N2-FS and H9N2 WT virus (Fig.2b).  102 
Apoptosis is a contributor to virulence (Roberts & Nichols, 1989; Tumpey et al., 103 
2000). Some viral proteins are able to induce apoptosis, such as NS1 and PB1-F2 104 
(Chanturiya et al., 2004; Chen et al., 2001; Zhirnov et al., 2002). A549 cells were 105 
infected with H9N2-FS and WT viruses at an MOI of 1 for 6 and 12 h and assessed 106 
for apoptosis. H9N2-FS virus infection produced less apoptotic cells (1.40% annexin 107 
V+ only at 6 hpi and 6.59%  at 12 hpi) than H9N2 WT virus (3.60% at 6 hpi and 108 
10.73% at 12hpi) (P < 0.05) (Fig.2c). Cells that were PI+ only, and annexin V+ PI+ 109 
showed no significant difference between H9N2-FS and H9N2 WT viruses. Overall, 110 
the data show that loss of PA-X in H9N2 virus has little effect on viral replication and 111 
produced less apoptosis in A549 cells. 112 
PA-X deficient H9N2 virus is less pathogenic and causes mild inflammatory 113 
response in mice relative to H9N2 wild type virus 114 
To assess the effect of PA-X on pathogenicity, mice (15 per group) were 115 
intranasally inoculated at 106 TCID50 with each virus. Clinical signs, mortality and 116 
weight loss were monitored over 14 days. Three virus-infected mice a day were 117 
humanely killed at 3, 5, and 7 days post infection (dpi), and lungs were collected for 118 
virus titration.  H9N2-FS virus infection resulted in no death, while H9N2 WT 119 
infection caused 33.3% mortality (Fig. 3a). No significant weight loss was observed in 120 
the H9N2-FS virus infected group, in contrast to the 15% weight loss of H9N2 WT 121 
virus infected mice (Fig. 3b).  122 
Histopathologically, H9N2-FS virus infected lung appeared nearly normal. 123 
However, in the H9N2 WT virus group, there were extensive vascular congestion, and 124 
cellular exudate (Fig. 3c). Viral titers of H9N2-FS virus infected lungs were 8-20 fold 125 
lower than those of H9N2 WT virus at 3, 5 and 7 dpi (P < 0.05) (Fig. 3d) consistent 126 
with the observed pathology.  127 
Increased pulmonary cytokine/chemokine expression contributes to the severity of 128 
influenza virus infection in humans and animal models (Bermejo-Martin et al., 2010; 129 
Hagau et al., 2010; Lam et al., 2010; Perrone et al., 2008). We determined the protein 130 
levels of seven cytokines and chemokines in the lungs of H9N2 WT and H9N2-FS 131 
virus infected mice at 3 and 5 dpi. Interleukin-1β (IL-1β), interleukin-6 (IL-6), the 132 
mouse equivalent of human IL-8 (KC), monocyte chemotactic protein 1 (MCP-1), 133 
macrophage inflammatory protein-1α (MIP-1α or CCL3), tumor necrosis factor-alpha 134 
(TNF-α) and interferon gamma (IFN-γ) levels from H9N2-FS virus infected mice 135 
were consistently lower than those of H9N2 WT virus infected mice at both time 136 
points (P < 0.05) (Fig.4). Collectively, these results demonstrate that PA-X in H9N2 137 
virus facilitates pathogenicity and up-regulated inflammatory response in mice.  138 
PA protein is less effective at suppressing protein expression without PA-X 139 
Inhibition of host protein synthesis by influenza virus can hinder host anti-viral 140 
response and promote virus replication (Katze et al., 1986a; Katze et al., 1986b). PA 141 
gene plays a major role in the suppression of host protein synthesis, which is partly 142 
mediated by PA-X (Desmet et al., 2013; Jagger et al., 2012). We compared the ability 143 
of PA of H9N2 WT and H9N2-FS viruses to suppress non-viral protein synthesis by 144 
co-transfections of Human embryonic kidney (293T) cells for 24 h with H9N2 WT PA 145 
or H9N2-FS PA, and pEGFP expression plasmids. eGFP expression was significantly 146 
higher by more than 20% when co-transfected with H9N2-FS PA, compared with 147 
H9N2 WT PA co-transfection (Fig.5a & b). Although the expression level of PA 148 
protein of H9N2-FS was higher than that of H9N2 WT, H9N2-FS PA plasmid was less 149 
effective in suppressing eGFP expression than H9N2 WT PA (Fig.5b). These results 150 
suggest that loss of PA-X in H9N2 virus reduces the host shut off ability of the virus 151 
in 293T cells.  152 
 153 
Discussion 154 
In the present study, we assessed the pathogenic capability of PA-X in avian 155 
H9N2 virus. PA-X deficient H9N2 (H9N2-FS) virus was less virulent than its H9N2 156 
WT counterpart. Absence of PA-X attenuated the H9N2 virus manifested as decreased 157 
viral replication, reduced apoptosis and dampened pro-inflammatory response. 158 
Furthermore, PA without PA-X was less able to suppress host protein synthesis. 159 
Therefore, we propose that PA-X in H9N2 virus is a virulence factor.  160 
Previous studies, however, have shown that PA-X deficient-H1N1 and -H5N1 161 
viruses are more pathogenic than their corresponding WT counterparts (Gao et al., 162 
2015; Hu et al., 2015; Jagger et al., 2012). Enhanced virulence of the 1918 H1N1 163 
virus deficient in PA-X might be due to alterations in the kinetics of host response 164 
(Jagger et al., 2012). Jagger et al. (2012) found that loss of PA-X expression in the 165 
1918 pandemic virus up-regulated inflammatory, apoptotic and T-lymphocyte 166 
signaling pathways. Elevated virulence manifested as increased PA expression, 167 
ribonucleoprotein polymerase activity and inflammatory response were the effects of 168 
PA-X deletion in pH1N1 and highly pathogenic H5N1 avian influenza viruses (Gao et 169 
al., 2015). PA-X is also an anti-virulence factor of avian H5N1 virus in avian species 170 
as well as in mice (Hu et al., 2015). H5N1 PA-X blunted the global host response in 171 
chicken lungs, which included markedly down-regulated genes associated with 172 
inflammation and cell death, and promoted anti-apoptotic activity in chicken and duck 173 
fibroblasts (Hu et al., 2015). In the present study, we found that PA-X played an 174 
opposite role in H9N2 virus. Apoptotic and inflammatory responses were decreased 175 
with H9N2 PA-X deficient virus. These observations indicate that the pro- or 176 
anti-virulence role of PA-X in influenza viruses is virus strain specific. 177 
Loss of PA-X expression decreased viral replication of H9N2 virus in vivo. H9N2 178 
PA-X deficient virus showed lower replication levels in mice than H9N2 WT at 3, 5 179 
and 7 dpi. The poor replication in murine lungs was directly related to the lower 180 
pathogenicity and reduced expression of inflammatory cytokines from H9N2 PA-X 181 
deficient virus infection. Hu J et al. (2015) showed that PA-X decreases the virulence 182 
of H5N1 virus through inhibiting viral replication and the host innate immune 183 
response. Jagger et al. (2012) showed that loss of PA-X in  1918 H1N1 virus did not 184 
affect viral replication in mice but increased pathogenicity through enhanced host 185 
immune response.  186 
Influenza virus infection can induce host shut off with rapid decline of host protein 187 
synthesis (Katze et al., 1986a; Katze et al., 1986b) to divert host resources towards 188 
viral replication. Inhibition of host protein synthesis also aids in dampening the 189 
anti-viral response. Therefore, virus induced host shut off is closely related to viral 190 
replication and pathogenicity. Recently, the roles of PA and PA-X in the inhibition of 191 
cellular protein synthesis were demonstrated (Desmet et al., 2013; Jagger et al., 2012). 192 
The N-terminal domain of PA, which includes the endonuclease active site, is 193 
sufficient to suppress protein expression, and PA-X showed a stronger effect than the 194 
corresponding N-terminal domain of PA. We previously showed that the absence of 195 
PA-X made PA less able to suppress co-transfected gene expression for pH1N1 and 196 
H5N1 viruses (Gao et al., 2015). Conceivably, loss of PA-X in these viruses could less 197 
effectively inhibit host protein synthesis, which would result in reduced viral 198 
replication and virulence. However, loss of PA-X does enhance the virulence of 1918 199 
H1N1, pH1N1 and H5N1 viruses (Gao et al., 2015; Hu et al., 2015; Jagger et al., 200 
2012). We speculate that the decrease in suppression of host protein synthesis 201 
exacerbates host inflammatory response and enhances apoptosis. As 1918 H1N1, 202 
pH1N1 and highly pathogenic H5N1 viruses could elicit significantly high levels of 203 
pro-inflammatory cytokines, loss of PA-X in such viruses could lead to more severe 204 
lung injury and contribute to the enhanced virulence (Kang et al., 2011; Ma et al., 205 
2011; Perrone et al., 2008). In the present study, H9N2 virus is largely a low 206 
pathogenicity virus and does not typically induce high levels of cytokines. PA protein 207 
in H9N2 virus was less able to suppress GFP expression in the absence of PA-X, 208 
suggesting that PA-X also plays a role in the inhibition of host protein synthesis. The 209 
level of host shut off by H9N2-FS could be less effective in promoting viral 210 
replication but more effective in eliciting an antiviral response. In summary, our 211 
results show that PA-X of H9N2 virus, unlike the more virulent H5N1, pH1N1 and 212 
1918 H1N1 viruses, is a pro-virulence factor in the facilitation of viral replication and 213 
pathogenicity, and that function of PA-X is virus strain specific. Therefore, the role of 214 
PA-X in other influenza viruses needs to be investigated. 215 
Methods 216 
Viruses and cells 217 
A/chicken/Hebei/LC/2008 (HB/08, H9N2) virus was isolated from a diseased 218 
chicken in Hebei province, China, in January 2008 and propagated in 10 day-old 219 
specific-pathogen-free (SPF) embryonated chicken eggs (Sun et al., 2011). 293T, 220 
MDCK, and A549 cells were maintained in Dulbecco’s modified Eagle’s medium 221 
(DMEM; Life Technologies, Foster City, CA, USA) supplemented with 10% fetal 222 
bovine serum (FBS; Life Technologies), 100 units/ml of penicillin and 100 g/ml of 223 
streptomycin.  224 
Generation of recombinant viruses by reverse genetics 225 
All eight gene segments have been previously amplified by reverse 226 
transcription-PCR (RT-PCR) from HB/08 virus and cloned into the dual-promoter 227 
plasmid, pHW2000 (Sun et al., 2011). PA-X deficient virus, H9N2-FS, was created by 228 
site-directed mutagenesis (QuikChange mutagenesis kit, Agilent) on the 229 
corresponding PA gene of H9N2 WT virus, which converted the frameshifting motif 230 
from UCC UUU CGU to AGC UUC AGA (U592A, C593G, U597C, C598A and 231 
U600A) to prevent the formation of PA-X (Jagger et al., 2012). PCR primer sequences 232 
used are available upon request. PA ORF was unaltered in H9N2-FS. Rescued viruses 233 
were detected using hemagglutination assays. The viruses were purified by sucrose 234 
density gradient centrifugation, and viral RNA was extracted and analyzed by 235 
RT-PCR, and each viral segment was sequenced to confirm sequence identity.  236 
Viral titration and replication kinetics 237 
Fifty % tissue culture infective dose (TCID50) was determined in MDCK cells 238 
using 10-fold serially diluted virus inoculated at 37°C and cultured for 72 h. The 239 
TCID50 values were calculated by the method of Reed and Muench (Reed & Muench, 240 
1938). MDCK and A549 cells were infected with viruses at an MOI of 0.01, overlaid 241 
with serum-free DMEM containing 2μg/ml TPCK-trypsin (Sigma–Aldrich) and 242 
incubated at 37°C. Supernatants of infected MDCK and A549 cells were harvested at 243 
6, 12, 24, 36, 48, 60, 72 and 84 hpi. Virus titers were determined by TCID50 in MDCK 244 
cells. Three independent experiments were performed. 245 
Mouse infections 246 
Fifteen mice (six week-old female BALB/c; Vital River Laboratory, Beijing, 247 
China) per group were anesthetized with Zoletil (tiletamine-zolazepam; Virbac S.A., 248 
Carros, France; 20 µg/g) and inoculated intranasally with 50 μl of 106 TCID50 of 249 
H9N2 diluted in phosphate-buffered saline (PBS). All mice were monitored daily for 250 
14 days, and mice losing 30% of their original body weight were humanely 251 
euthanized. Three mice were euthanized on 3, 5 and 7 dpi for the determination of 252 
lung virus titers, histopathology and cytokine levels. Lungs were collected and 253 
homogenized in cold PBS. Virus titers were determined by TCID50. All animal 254 
research was approved by the Beijing Association for Science and Technology and 255 
complied with Beijing Laboratory Animal Welfare and Ethical Guidelines as issued 256 
by the Beijing Administration Committee of Laboratory Animals. 257 
Histopathology 258 
A portion of the lung from each euthanized mouse at 5 dpi was fixed in 10% 259 
phosphate-buffered formalin and processed for paraffin embedding. Each 5 μm 260 
section was stained with hematoxylin and eosin and examined for histopathological 261 
changes. Images were captured with a Zeiss Axioplan 2IE epifluorescence 262 
microscope. 263 
Quantification of cytokine/chemokine protein levels in mouse lungs 264 
Levels of cytokines/chemokines including IFN-γ, IL-1β, IL-6, KC, TNF-α, 265 
MIP-1α or CCL3 and MCP-1 in lungs were determined by cytometric bead array 266 
assays (BD Cytometric BEAD Array Mouse Inflammation Kit; BD Bioscience, San 267 
Diego, CA, USA). Briefly, 50 µl mouse inflammation capture bead suspension and 50 268 
µl detection reagent were added to an equal amount of sample and incubated in the 269 
dark for 2 h at room temperature. Subsequently, each sample was washed  with 1 ml 270 
wash buffer and then centrifuged at 200 × g at room temperature for 5 min. 271 
Supernatants were discarded and a further 300 µl wash buffer was added. Samples 272 
were analyzed on a BD FACS Array bioanalyzer (BD Bioscience). Data were 273 
analyzed using BD CBA Software (BD Bioscience). Each chemokine or cytokine was 274 
computed as pg/ml of homogenate. 275 
Cell death assays 276 
Virus infection assays were conducted in 6 well plates. Cells were seeded at a 277 
density of 1×106 cells/well for overnight incubation in infection media (cell growth 278 
media with 1% bovine serum albumin was used in place of FBS). Cells were then 279 
infected with virus at 1.0 MOI for 12 h. Cells pooled from the supernatant and 280 
monolayer were then harvested, washed and stained with FITC labeled annexin V and 281 
propidium iodide (PI) (Becton Dickinson, San Jose, CA) for 20 min. After a final 282 
wash, cells were resuspended in 100 μl FACs wash buffer (PBS containing 3% BSA 283 
and 0.01% sodium azide) and analyzed on the FACs Calibur (BD Biosciences) with 284 
Flow Jo software (version 7.6.1). Cell death (apoptosis and necrosis) was defined as 285 
annexin-V+ and PI+, while apoptotic cells were annexin-V+ only. Viable cells were 286 
considered as neither annexin-V nor PI positive. 287 
Western blotting 288 
Total cell protein lysates were extracted from transfected 293T cells or infected 289 
MDCK cells with CA630 lysis buffer (150 mM NaCl, 1% CA630 detergent, 50 mM 290 
Tris base [pH 8.0]). Cellular proteins were separated by 12% sodium dodecyl 291 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 292 
polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences, Germany). 293 
Each PVDF membrane was blocked with 0.1% Tween 20 and 5% nonfat dry milk in 294 
Tris-buffered saline and subsequently incubated with a primary antibody. Primary 295 
antibodies were specific for influenza A virus PA (1:3000, GeneTex, USA), influenza 296 
A virus PA-X [diluted 1:2000, polyclonal rabbit antiserum against a H5N1 X-ORF 297 
derived peptide(CAGLPTKVSHRTSPA), Genscript, China)], influenza A virus PB1 298 
(diluted 1:3000, Thermo Fisher Scientific, USA), GFP (1:1000, Abcam, UK), β-actin 299 
(1:1000, Santa Cruz, USA). The secondary antibody used was either horseradish 300 
peroxidase (HRP)-conjugated anti-mouse antibody or HRP-conjugated anti-rabbit 301 
antibody (diluted 1:10,000 Jackson ImmunoResearch USA), as appropriate. HRP 302 
presence was detected using a Western Lightning chemiluminescence kit (Amersham 303 
Pharmacia, Freiburg, Germany), following the manufacturer’s protocol.  304 
Statistics 305 
All statistical analyses were performed using GraphPad Prism Software Version 306 
5.0 (GraphPad Software Inc., San Diego, CA, USA). The two treatment methods were 307 
compared by two-tailed Student’s t-test, and multiple comparisons were carried out by 308 
two-way analysis of variance (ANOVA) considering time and virus as factors. 309 
Differences were considered statistically significant at P < 0.05. All data are reported 310 
as the mean ± standard deviation (SD).  311 
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Figure 1. Generation of H9N2 PA-X deficient viruses. (a) The frameshifting motif 457 
of UCC UUU CGU was mutated to AGC UUC AGA (in red) in the PA gene which 458 
did not alter the PA ORF but abrogated the expression of PA-X. (b) PA-X protein 459 
expression was abolished in H9N2-FS virus infected cells. MDCK cells were infected 460 
with H9N2-FS and H9N2 WT virus for 12 h. Western blotting was performed on cell 461 
lysates with antibodies against PA-X or PB1 or β-actin, as indicated, followed by 462 
AP-conjugated secondary antibodies. 463 
Figure 2. Growth of H9N2 WT and FS viruses and induction of apoptosis. Virus 464 
growth curves of H9N2 WT and H9N2-FS viruses in MDCK cells (a) and A549 (b) 465 
cells over 84 h. (c) Cell death was determined in A549 cells by detection of annexin+ 466 
and/or PI+ at 6 and 12 hpi of H9N2 WT or H9N2-FS virus at 1.0 MOI. Representative 467 
dual-labeled quadrants of bivariant fluorescence dot plots showing the induction of 468 
apoptosis in infected cells. Apoptotic cells, positive for annexin V but not PI, were 469 
identified in the right lower quadrant. Cells positive for PI but not annexin V 470 
(indicative of necrosis) were identified in the right upper quadrant. MOCK = 471 
uninfected control cells. Each value represents the mean of three independent 472 
experiments performed in triplicates; error bars indicate standard deviations (SD). * 473 
indicates significant difference between FS virus and wild type virus (P < 0.05). .  474 
Figure 3. Pathogenicity of H9N2 WT and H9N2-FS viruses in mice. (a) Reduced 475 
survival (percentage) was found with H9N2 WT virus infected mice over a 14 day 476 
period (inoculation at day 0). (b) H9N2 WT virus infected mice showed significant 477 
weight loss, unlike H9N2-FS virus and mock infected mice. Any mouse that lost more 478 
than 30% of its body weight was euthanized. (c) Histopathology in lung of H9N2-FS 479 
virus infected mice was mild to normal compared with corresponding H9N2 WT virus 480 
infection which showed vascular congestion and cellular infiltration of bronchioles 481 
and alveoli. Scale bars, 100 µm. (d) Mean of viral lung load ± SD was based on log10 482 
TCID50 determination in MDCK cells. * indicates significant difference between 483 
H9N2 WT and H9N2-FS virus (P < 0.05). Means of the data of three mice per group 484 
are shown, and error bars are SDs. 485 
Figure 4. Detection of cytokine/chemokine proteins in lungs of mice infected with 486 
H9N2 WT and H9N2-FS viruses. Mean cytokine/chemokine levels ± SDs are shown 487 
(n=3). * indicates significant difference between H9N2-FS and H9N2 WT (P < 0.05).  488 
Figure 5. PA without PA-X is less able to suppress co-expressed GFP in 293T cells. 489 
(a) eGFP expression plasmid was co-transfected with PA plasmid derived from H9N2 490 
WT or H9N2-FS viruses, or with mock plasmid (control pcDNA3.1). eGFP 491 
fluorescence was captured at 24 h post transfection. GFP fluorescence (green) is 492 
shown in the left panel, and merged with DAPI staining fluorescence is shown in the 493 
right panel. The GFP expression levels were quantified by fluorescence intensity. The 494 
fluorescence intensities were analyzed with Image-Pro-Plus (Media Cybernetics). 495 
Relative fluorescence intensity of each group as compared with control was shown as 496 
histograms. Values shown are means of the results of three independent experiments ± 497 
SDs. (b) PA and GFP protein expression were determined by Western blotting analysis 498 
using anti-PA and anti-GFP antibody. Anti-β-actin antibody was used as loading 499 
control. Protein bands were quantified by densitometry. Protein levels of PA and GFP 500 
relative to β-actin are shown as histograms. Stronger expression of PA, in the absence 501 
of PA-X, derived from H9N2-FS virus did not lead greater inhibition of GFP 502 
expression. The results shown are representative data from three independent 503 
experiments. Error bars indicate SDs. * indicates significant difference between H9N2 504 
WT and H9N2-FS virus (P < 0.05). 505 





